$3.54
6.35% yesterday
Nasdaq, Sep 19, 10:09 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$3.54
-2.42 40.60% 1M
-43.50 92.47% 6M
-43.08 92.41% YTD
-50.22 93.42% 1Y
-95,164.26 100.00% 3Y
-1,477,787.46 100.00% 5Y
-101,870,999,996.46 100.00% 10Y
-444,379,823,996.46 100.00% 20Y
Nasdaq, Closing price Fri, Sep 19 2025
-0.24 6.35%

Key metrics

Basic
Market capitalization
$3.4m
Enterprise Value
$850.0k
Net debt
positive
Cash
$2.6m
Shares outstanding
100.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.4
EV/Sales
0.1 | 0.1
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
66.2%
Return on Equity
-162.7%
ROCE
-197.2%
ROIC
-319.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$8.8m | $9.3m
EBITDA
$-8.1m | -
EBIT
$-8.4m | $-8.6m
Net Income
$-9.9m | $-200.0k
Free Cash Flow
$-9.3m
Growth (TTM | estimate)
Revenue
-1.2% | 6.5%
EBITDA
50.0% | -
EBIT
49.2% | 21.7%
Net Income
50.6% | 98.1%
Free Cash Flow
37.5%
Margin (TTM | estimate)
Gross
63.2%
EBITDA
-92.1% | -
EBIT
-95.6%
Net
-112.1% | -2.1%
Free Cash Flow
-105.8%
More
EPS
$-94.6
FCF per Share
$-93.0
Short interest
2.5%
Employees
38
Rev per Employee
$230.0k
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,012 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

Buy
86%
Hold
14%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8.79 8.79
1% 1%
100%
- Direct Costs 3.24 3.24
15% 15%
37%
5.55 5.55
9% 9%
63%
- Selling and Administrative Expenses 12 12
24% 24%
141%
- Research and Development Expense 2.43 2.43
54% 54%
28%
-8.09 -8.09
50% 50%
-92%
- Depreciation and Amortization 0.31 0.31
11% 11%
4%
EBIT (Operating Income) EBIT -8.40 -8.40
49% 49%
-96%
Net Profit -9.85 -9.85
51% 51%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
GlobeNewsWire
one day ago
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
Neutral
GlobeNewsWire
2 days ago
Watch the “What This Means” segment here
Neutral
GlobeNewsWire
11 days ago
Awarded grant supports dedicated pediatric continuous renal replacement therapy (CRRT) device in development for patients between 2.5 and 20 kg where therapeutic options are scarce Company working to advance Vivian™ towards an investigational device study to support the path to US regulatory clearance MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis Inc. (Nasdaq: NUWE), announced today ...
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO John Erb
Employees 38
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today